RxDoctor Payments DataLook up a doctor →

Michael Kim, MD

Interventional Cardiology · Manhasset, NYNPI 1922020155

Payments from drug & device makers

$1,355,113in general payments, 2019–2025

Across 777 payments — averaging $1744.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cathworks, Inc.$615K
  • Abbott$224K
  • Shockwave Medical, Inc$191K
  • Cardiovascular Systems Inc.$140K
  • Medtronic$63K
  • Saranas, Inc.$54K
  • plus $68K from 21 others
$263in research payments, 2019–2025

Across 3 payments — averaging $87.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$263

What the payments were for

  • Consulting fees$2500%
  • Speaking & faculty fees$85,90863%
  • Travel & lodging$11,2888%
  • Food & beverage$38,71128%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cathworks, Inc.28$615,152
Abbott136$223,890
Shockwave Medical, Inc45$191,138
Cardiovascular Systems Inc.106$140,273
Medtronic(2 entities)176$62,987
Saranas, Inc.23$54,160
Abiomed74$34,950
Spectrawave, Inc12$21,319
Boston Scientific116$6,241
Philips North America LLC18$1,134
Heartflow, Inc.6$589
Acist Medical Systems, Inc.6$514
Cvrx, Inc.4$438
Terumo Medical Corporation3$379
Johnson & Johnson9$340
Cordis US CORP.2$251
Arrow International, Inc.2$214
Penumbra, Inc.2$192
Recor Medical Inc1$180
Endologix LLC1$168
Bolton Medical Inc1$149
Siemens Medical Solutions USA, Inc.1$143
Inari Medical, Inc.1$112
Novo Nordisk1$110
Cardiva Medical, Inc.1$44
AbbVie1$24
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,355,113 in reported general payments places this provider in the 95th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Medicare billing

Part B allowed, 2024
$185,076
Medicare patients
217
Services billed
776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate52$878
Atorvastatin Calcium51$673
ClopidogrelClopidogrel Bisulfate37$357
Lisinopril14$161
Amlodipine Besylate19$136
Carvedilol11$78
Hydrochlorothiazide13$67

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Manhasset

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →